NIH/CDC/FDA SBIR Program (R43/R44) for Clinical Trial Optional Projects
The NIH, CDC, and FDA SBIR program provides funding to U.S. small businesses to support early feasibility studies that can lead to later R&D and commercial products. Applicants may propose work under the R43/R44 mechanism, with clinical trial activity optional depending on the project plan. The program is intended to move innovations toward commercialization.
Source
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers